| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $112.0M | -1.0% | -1.7% |
| Cost of Revenue | $29.2M | +4.1% | +11.3% |
| Gross Profit | $82.8M | -2.6% | -5.6% |
| R&D Expense | $22.6M | -3.2% | +7.3% |
| SG&A Expense | $34.0M | +6.1% | +2.0% |
| Operating Income | $7.8M | -73.8% | +175.0% |
| Pre-tax Income | $6.7M | -76.6% | +167.9% |
| Income Tax | $536K | -69.9% | -82.0% |
| Net Income | $6.1M | -77.1% | +147.9% |
| EPS (Basic) | $0.05 | -77.3% | +150.0% |
| EPS (Diluted) | $0.01 | -66.7% | +110.0% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $139.9M | -21.7% | +39.2% |
| Accounts Receivable | $62.9M | -5.3% | +8.8% |
| Current Assets | $242.8M | -19.1% | +16.3% |
| Total Assets | $555.8M | -11.2% | +2.9% |
| Current Liabilities | $222.0M | -22.4% | -8.0% |
| Long-term Debt | $98.2M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $26.3M | — | — |
| Capital Expenditures | $1.6M | — | — |
| Investing Cash Flow | -$20.5M | — | — |
| Financing Cash Flow | $10.1M | — | — |
| Free Cash Flow | $24.7M | — | — |
| — |
| Total Liabilities | $400.6M | -15.4% | +5.3% |
| Stockholders' Equity | $155.2M | +1.7% | -3.0% |